| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/23/2003 | CN1432020A 嘌呤衍生物 Purine derivatives |
| 07/23/2003 | CN1432018A Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 07/23/2003 | CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1432011A Benzoamide piperidine compounds as substance P antagonists |
| 07/23/2003 | CN1432009A Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1432007A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/23/2003 | CN1431941A 挤压模 Extrusion die |
| 07/23/2003 | CN1431904A Protease inhitors |
| 07/23/2003 | CN1431901A S-methyl-dihydro-zipprasidone for treatment of psychiatric and ocular disorders |
| 07/23/2003 | CN1431898A Methods of use of penicillamines for treatment of conditions resulting from DNA damage |
| 07/23/2003 | CN1431003A Medicine for curing cerebral concussion and injuries from falls |
| 07/23/2003 | CN1430989A Ointment of Chinese herbal medicine for reactivating nerve and its mfg. method |
| 07/23/2003 | CN1430960A Central nerve antalgic preparation through nasal cavity administration |
| 07/23/2003 | CN1115342C Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products |
| 07/23/2003 | CN1115336C 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulator |
| 07/23/2003 | CN1115159C Red sage contg. medicine compsn. and its prepn. process and application |
| 07/23/2003 | CN1115155C Sobering-up beverage and its prepn. method |
| 07/23/2003 | CN1115150C Pharmaceutical compsns. contg. ibuprofen and domperidone for treatment of migraine |
| 07/23/2003 | CN1115149C Aqueous process for mfg. paroxetine solid dispersions |
| 07/22/2003 | USRE38200 Indole-2,3-dione-3-oxime derivatives |
| 07/22/2003 | US6596900 Brain, nervous system, neurodegenerative, gastrointestinal, sleep, rheumatic, and psychological disorders; analgesics, antiepileptic agents |
| 07/22/2003 | US6596869 Reacting cyanoquinuclidine compound with isoamyl nitrite for nitrosation |
| 07/22/2003 | US6596867 Bone disorders |
| 07/22/2003 | US6596773 Central nervous system disorders |
| 07/22/2003 | US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are |
| 07/22/2003 | US6596764 Method of preparing diacetyl rhein |
| 07/22/2003 | US6596756 Treatment of fibromyalgia |
| 07/22/2003 | US6596751 α-substituted carboxylic acid derivatives |
| 07/22/2003 | US6596749 Neuropeptide y receptor ligand |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596745 Method for treating fibrotic diseases with azolium chroman compounds |
| 07/22/2003 | US6596743 Carbamic acid derivatives |
| 07/22/2003 | US6596740 Nicotine mucosal spray |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596732 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 07/22/2003 | US6596731 Substituted imidazo[1,2-A] pyridine derivatives |
| 07/22/2003 | US6596730 Phenyl urea and phenyl thiourea derivatives |
| 07/22/2003 | US6596722 Serotonin reuptake inhibitors/HT3 receptor antagonists useful for treatment of depression, psychosis, anxiety disorders, panic disorder, obsessive compulsive disorder, and eating disorders |
| 07/22/2003 | US6596718 7-Morpholin-4yl-benzothiazole amide derivatives |
| 07/22/2003 | US6596709 6-sulphanoyl-3-quinolylphosphonic acid compounds |
| 07/22/2003 | US6596706 For the treatment of circulatory diseases cerebral diseases |
| 07/22/2003 | US6596701 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/22/2003 | US6596474 Kit for use in the detection and treatment of nervous system disorders |
| 07/22/2003 | US6596302 Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 07/22/2003 | US6596301 Lactobacillus helveticus fermented sour milk; ameliorating tension, depression fatigue and emotional derangement |
| 07/22/2003 | US6596298 Pullulan and antimicrobially effective amounts of thymol, methyl salicylate, eucalyptol and menthol |
| 07/22/2003 | US6596295 Aqueous solution for treating degenerative or autoimmune diseases and/or as an immunomodulatory agent |
| 07/22/2003 | US6596269 Methods of treating chronic pain |
| 07/22/2003 | CA2353693C Pharmaceutical composition containing citalopram |
| 07/22/2003 | CA2294422C Tartrate salt of a substituted dipeptide |
| 07/22/2003 | CA2276203C N-(pyridinylamino)isoindolines and related compounds |
| 07/22/2003 | CA2228572C Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| 07/21/2003 | CA2416791A1 A receptor-ligand pairing for immune response |
| 07/21/2003 | CA2368656A1 Receptor-ligand pairing for anti-inflammatory response |
| 07/17/2003 | WO2003058021A2 Novel apoptosis-inducing dna sequences |
| 07/17/2003 | WO2003057898A2 Methods and materials for modulating p2x2 |
| 07/17/2003 | WO2003057856A2 Dominant negative proteins and methods thereof |
| 07/17/2003 | WO2003057854A2 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | WO2003057835A2 Pak5-related compositions and methods |
| 07/17/2003 | WO2003057730A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 07/17/2003 | WO2003057721A2 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 07/17/2003 | WO2003057699A1 Dibenzodiazepine derivates, their preparation and use |
| 07/17/2003 | WO2003057698A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/17/2003 | WO2003057697A1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics |
| 07/17/2003 | WO2003057696A1 Deazapurines and uses thereof |
| 07/17/2003 | WO2003057691A1 Process and intermediates for pyridazinone antidiabetic agents |
| 07/17/2003 | WO2003057688A2 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
| 07/17/2003 | WO2003057684A1 Process for the preparation of simvastatin |
| 07/17/2003 | WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | WO2003057674A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | WO2003057673A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | WO2003057672A2 Tetrahydroquinoline analogues as muscarinic agonists |
| 07/17/2003 | WO2003057671A1 Biaryl compound and use thereof |
| 07/17/2003 | WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057380A2 Compositions including ammonia oxidizing bacteria and methods of using same |
| 07/17/2003 | WO2003057252A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | WO2003057220A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 07/17/2003 | WO2003057219A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 07/17/2003 | WO2003057216A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 07/17/2003 | WO2003057215A1 Neurotrophic factor production/secretion accelerator |
| 07/17/2003 | WO2003057211A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases. |
| 07/17/2003 | WO2003057196A1 Drug mixture with enhanced dissolution rate |
| 07/17/2003 | WO2003057170A2 Oral insulin therapy |
| 07/17/2003 | WO2003057169A2 4-dedimethylamino tetracycline compounds |
| 07/17/2003 | WO2003057166A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/17/2003 | WO2003057165A2 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS |
| 07/17/2003 | WO2003057153A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 07/17/2003 | WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | WO2003057147A2 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003056931A1 Chewing gum composition for eliminating nicotine |
| 07/17/2003 | WO2003056925A1 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex |
| 07/17/2003 | WO2003056899A2 Nitric oxide donors for treatment of disease and injury |
| 07/17/2003 | WO2003046172A3 Alzheimer’s disease model |
| 07/17/2003 | WO2003043974A3 New pharmaceutical compounds |
| 07/17/2003 | WO2003031595A3 Molecules for disease detection and treatment |
| 07/17/2003 | WO2003030827A3 Compositions for and methods of treating and preventing sirs/sepsis |
| 07/17/2003 | WO2003022809A3 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |